These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 28206828)

  • 1. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
    Motl RW; Cohen JA; Benedict R; Phillips G; LaRocca N; Hudson LD; Rudick R;
    Mult Scler; 2017 Apr; 23(5):704-710. PubMed ID: 28206828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.
    Feys P; Lamers I; Francis G; Benedict R; Phillips G; LaRocca N; Hudson LD; Rudick R;
    Mult Scler; 2017 Apr; 23(5):711-720. PubMed ID: 28206826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.
    Benedict RH; DeLuca J; Phillips G; LaRocca N; Hudson LD; Rudick R;
    Mult Scler; 2017 Apr; 23(5):721-733. PubMed ID: 28206827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.
    Balcer LJ; Raynowska J; Nolan R; Galetta SL; Kapoor R; Benedict R; Phillips G; LaRocca N; Hudson L; Rudick R;
    Mult Scler; 2017 Apr; 23(5):734-747. PubMed ID: 28206829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.
    Sandroff BM; Motl RW; Sosnoff JJ; Pula JH
    Gait Posture; 2015 Jan; 41(1):222-7. PubMed ID: 25455207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
    Voloshyna N; Havrdová E; Hutchinson M; Nehrych T; You X; Belachew S; Hotermans C; Paes D
    Eur J Neurol; 2015 Mar; 22(3):570-7. PubMed ID: 25511792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.
    Goldman MD; Motl RW; Scagnelli J; Pula JH; Sosnoff JJ; Cadavid D
    Neurology; 2013 Nov; 81(21):1856-63. PubMed ID: 24174581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
    Phan-Ba R; Calay P; Grodent P; Delrue G; Lommers E; Delvaux V; Moonen G; Nagels G; Belachew S
    NeuroRehabilitation; 2012; 30(4):261-6. PubMed ID: 22672939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The timed 25-foot walk in a large cohort of multiple sclerosis patients.
    Kalinowski A; Cutter G; Bozinov N; Hinman JA; Hittle M; Motl R; Odden M; Nelson LM
    Mult Scler; 2022 Feb; 28(2):289-299. PubMed ID: 34100297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS.
    Hobart J; Blight AR; Goodman A; Lynn F; Putzki N
    Neurology; 2013 Apr; 80(16):1509-17. PubMed ID: 23535489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis.
    Coleman CI; Sobieraj DM; Marinucci LN
    Curr Med Res Opin; 2012 Jan; 28(1):49-56. PubMed ID: 22073939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The six spot step test: a new measurement for walking ability in multiple sclerosis.
    Nieuwenhuis MM; Van Tongeren H; Sørensen PS; Ravnborg M
    Mult Scler; 2006 Aug; 12(4):495-500. PubMed ID: 16900764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
    Bethoux FA; Palfy DM; Plow MA
    Int J Rehabil Res; 2016 Jun; 39(2):134-9. PubMed ID: 26926380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
    Learmonth YC; Dlugonski DD; Pilutti LA; Sandroff BM; Motl RW
    Mult Scler; 2013 Nov; 19(13):1784-91. PubMed ID: 23587605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-efficacy and Walking Performance in Persons With Multiple Sclerosis.
    Motl RW; Balto JM; Ensari I; Hubbard EA
    J Neurol Phys Ther; 2017 Apr; 41(2):114-118. PubMed ID: 28263255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
    Stellmann JP; Vettorazzi E; Poettgen J; Heesen C
    J Neurol Sci; 2014 Nov; 346(1-2):99-106. PubMed ID: 25156343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.